Pages that link to "Q36806022"
Jump to navigation
Jump to search
The following pages link to Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals (Q36806022):
Displaying 45 items.
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro (Q28293679) (← links)
- Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV (Q33395672) (← links)
- Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251. (Q33649657) (← links)
- Mucosal infection and vaccination against feline immunodeficiency virus (Q33732753) (← links)
- Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection (Q33744806) (← links)
- In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. (Q33783369) (← links)
- Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV (Q33786143) (← links)
- Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials (Q35049812) (← links)
- Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS (Q35110966) (← links)
- 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques (Q35129347) (← links)
- A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques (Q35132138) (← links)
- Development of a vaccine for the prevention of AIDS, a critical appraisal (Q35159582) (← links)
- Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. (Q35365474) (← links)
- Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys (Q35830811) (← links)
- Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. (Q35833990) (← links)
- A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. (Q35837607) (← links)
- Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. (Q35839114) (← links)
- Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques (Q35841255) (← links)
- Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques (Q35860324) (← links)
- Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. (Q35877932) (← links)
- Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. (Q36175538) (← links)
- Psoralen Inactivation of Viruses: A Process for the Safe Manipulation of Viral Antigen and Nucleic Acid (Q36333651) (← links)
- Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen (Q36629359) (← links)
- Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines (Q36630114) (← links)
- Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia (Q36636056) (← links)
- Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. (Q36640342) (← links)
- Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac (Q36653572) (← links)
- Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine (Q36698665) (← links)
- Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro (Q36797252) (← links)
- Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages (Q36797335) (← links)
- The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1 (Q36839199) (← links)
- Method for detection of simian immunodeficiency virus neutralizing antibodies using a noncommercial antigen capture enzyme-linked immunosorbent assay. (Q37121446) (← links)
- Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay (Q37243637) (← links)
- Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences (Q37577555) (← links)
- Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy (Q40173243) (← links)
- Production of Immunogenic HIV-1 Viruslike Particles in Stably Engineered Monkey Cell Lines (Q41706764) (← links)
- Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo (Q41981904) (← links)
- Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection (Q42018824) (← links)
- A macaque adherent cell line that expresses human CD4 is susceptible to SIV: utility for assessing neutralizing antibody (Q42804317) (← links)
- Functional and Immunological Characterization of SIV Envelope Glycoprotein Produced in Genetically Engineered Mammalian Cells (Q42808224) (← links)
- Characterization and downstream processing of HIV-1 core and virus-like-particles produced in serum free medium (Q57774982) (← links)
- Long–term protection against SIV–induced disease in macaques vaccinated with a live attenuated HIV–2 vaccine (Q64134852) (← links)
- Vaccination of Macaques with SIV Conserved Envelope Peptides Suppressed Infection and Prevented Disease Progression and Transmission (Q67465920) (← links)
- HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques (Q71803147) (← links)